SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against RxSight, Inc. (NASDAQ: RXST)

Core Viewpoint - A shareholder has filed a securities class action lawsuit against RxSight, Inc. for allegedly overstating product demand and failing to disclose sales declines due to adoption challenges and structural issues [1][3]. Summary by Relevant Sections Lawsuit Details - The lawsuit is on behalf of investors who purchased or acquired RxSight securities between November 7, 2024, and July 8, 2025 [1]. - Defendants are accused of misrepresenting the demand for RxSight's products and not revealing significant challenges affecting sales [3]. Legal Process - Investors wishing to serve as lead plaintiffs must file necessary documents by September 22, 2025 [4]. - Participation in the lawsuit does not require serving as a lead plaintiff, and all representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [4]. Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has a strong track record in class action litigation [5].